COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1676: Articles 16751-16760  | Next

The BioNTech / Pfizer vaccine BNT162b2 induces class-switched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization
Lixenfeld, A. S., Kuensting, i., Martin, E. L., von Kopylow, V., Lehrian, S., Lunding, H. B., Buhre, J. S., Quack, J. L., Steinhaus, M., Graf, T., Ehlers, M., Rahmoeller, J.
10.1101/2021.03.10.21252001 — Posted: 2021-03-12
Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states
Wu, F., Xiao, A., Zhang, J., Moniz, K., Endo, N., Armas:, F., Bushman, M., Chai, P. R., Duvallet, C., Erickson, T. B., Foppe, K., Ghaeli, N., Gu, X., Hanage, W. P., Huang, K. H., Lee, W. L., Matus, M., McElroy, K. A., Rhode, S. F., Wuertz, S., Thompson, J., Alm, E. J.
10.1101/2021.03.10.21253235 — Posted: 2021-03-12 Discussion: Offsite
Development and validation of a clinical and genetic model for predicting risk of severe COVID-19
Dite, G. S., Murphy, N. M., Allman, R.
10.1101/2021.03.09.21253237 — Posted: 2021-03-12
Kinetics and seroprevalence of SARS-CoV-2 antibodies - a comparison of 3 different assays
Kahre, E., Galow, L., Unrath, M., Haag, L., Blankenburg, J., Dalpke, A., Lueck, C., Berner, R., Armann, J. P.
10.1101/2021.03.10.21253273 — Posted: 2021-03-12
How do Hemodialysis Center Prevent the Secondary COVID-19 Transmission in Poverty-Stricken Rural Region of China: Eperiences and Strategies
Gu, Y., Wang, Y., Zhou, J., Deng, Y., Shao, F.
10.1101/2021.03.09.21252639 — Posted: 2021-03-12
A phase 2 study of the inhaled pan-JAK inhibitor TD-0903 in severe COVID-19: Part 1
Singh, D., Bogus, M., Moskalenko, V., Lord, R., Moran, E. J., Crater, G. D., Bourdet, D. L., Pfeifer, N. D., Woo, J., Kaufman, E., Lombardi, D. A., Weng, E. Y., Nguyen, T., Woodcock, A., Haumann, B., Saggar, R.
10.1101/2021.03.09.21252944 — Posted: 2021-03-12
An Extended COVID-19 Epidemiological Model with Vaccination and Multiple Interventions for Controlling COVID-19 Outbreaks in the UK
Zhang, S., Bi, G., Yang, Y., Qi, J., Li, S., Mao, X., Peng, R., Yang, P.
10.1101/2021.03.10.21252748 — Posted: 2021-03-12
Acceptability of contact management and care of simple cases of COVID-19 at home: a mixed-method study in Senegal
Ba, M. F., Ridde, V., Diallo, A. I., Tine, J. A. D., Kane, B., Gaye, I., Traore, Z., Bonnet, E., Faye, A.
10.1101/2021.03.10.21253266 — Posted: 2021-03-12
The impact of the UK's first COVID-19 lockdown on rates of violence and aggression on psychiatric inpatient wards
Payne-Gill, J., Whitfield, C., Beck, A.
10.1101/2021.03.10.21253244 — Posted: 2021-03-12
Immune response during lactation after anti-SARS-CoV2 mRNA vaccine
Golan, Y., Prahl, M., Cassidy, A., Wu, A. H. B., Jigmeddagva, U., Lin, C. Y., Gonzalez, V. J., Basilio, E., Warrier, L., Buarpung, S., Asiodu, I. V., Ahituv, N., Flaherman, V. J., Gaw, S. L.
10.1101/2021.03.09.21253241 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).